Research Program Highlights
The Leukemia & Lymphoma Society's (LLS's) research programs are creating tomorrow's treatments and laying the groundwork for the ultimate cures. Highlights include:
- The Specialized Center of Research (SCOR), LLS's largest and most innovative research initiative, emphasizes collaboration across universities, labs and national boundaries. It brings together some of the country's brightest blood cancer researchers to help speed the discovery of new drugs and treatments.
- The Translational Research Program (TRP) supports research that shows strong promise for "translating" findings made in laboratories into actual clinical blood cancer treatments and prevention tactics. The program works to speed along the therapies' development.
- The Career Development Program provides stipends to investigators in the early stages of their careers. The awards allow them to devote themselves to leukemia, lymphoma and myeloma research.
- The Therapy Acceleration Program, launched in 2007, helps speed blood cancer research along during what can be an otherwise slow-moving process. It's helped bring more treatments to more patients faster.
The program helps promising new treatments reach patients quickly by:
- providing the funding and support needed to help researchers bring their projects closer to the product stage
- funding projects within biotechnology companies on the cutting-edge of blood cancer therapies
- helping patients gain easier access to clinical trials by working to overcome obstacles that may prevent them from participating, such as inconvenient locations and lack of insurance coverage